<DOC>
	<DOCNO>NCT00044187</DOCNO>
	<brief_summary>Olanzapine currently market treatment schizophrenia acute manic episode bipolar 1 disorder . This Anti-obesity Agent currently market management obesity . In study , Anti-obesity Agent test see treat weight gain may associate take olanzapine . The purpose study determine safety olanzapine give combination Anti-obesity Agent side effect might associate whether weight-gain agent help treat weight gain may associate take olanzapine .</brief_summary>
	<brief_title>The Assessment Weight-Gain Agent Treatment Olanzapine-Associated Anti-Obesity Agent Patients With Schizophrenia , Schizophreniform Disorder , Schizoaffective Disorder , Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<mesh_term>Anti-Obesity Agents</mesh_term>
	<criteria>Eligibility Criteria : You must age 18 65 . If reach 66th birthday , able participate . You must diagnose schizophrenia , schizoaffective disorder , schizophreniform disorder , bipolar I disorder take olanzapine . You must able visit doctor 's office schedule next 4 month . You history illness would cause weight loss gain near future . You take remoxipride within past 6 month . You allergic olanzapine Antiobesity Agent . You uncontrolled high blood pressure , congestive heart failure , stroke . You serious medical illness , heart , liver , kidney disease . You pregnant breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>schizoaffective disorder</keyword>
	<keyword>schizophreniform disorder</keyword>
	<keyword>bipolar I disorder</keyword>
</DOC>